BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nguyen TH, Thrift AP, Rugge M, El-Serag HB. Prevalence of Barrett's esophagus and performance of societal screening guidelines in an unreferred primary care population of U.S. veterans. Gastrointest Endosc 2021;93:409-419.e1. [PMID: 32565183 DOI: 10.1016/j.gie.2020.06.032] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Sawas T, Katzka DA. Esophageal adenocarcinoma phenotypes and risk factors. Curr Opin Gastroenterol 2022;38:423-7. [PMID: 35762703 DOI: 10.1097/MOG.0000000000000844] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Dumoulin FL, Rodriguez-monaco FD, Ebigbo A, Steinbrück I. Artificial Intelligence in the Management of Barrett’s Esophagus and Early Esophageal Adenocarcinoma. Cancers 2022;14:1918. [DOI: 10.3390/cancers14081918] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Shaheen NJ, Falk GW, Iyer PG, Souza RF, Yadlapati RH, Sauer BG, Wani S. Diagnosis and Management of Barrett's Esophagus: An Updated ACG Guideline. Am J Gastroenterol 2022;117:559-87. [PMID: 35354777 DOI: 10.14309/ajg.0000000000001680] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 9.0] [Reference Citation Analysis]
4 Nguyen TH, Thrift AP, Ketwaroo GA, Du XL, Leon Novelo L, George R, Rosen DG, El-Serag HB. External validation of a model determining risk of neoplastic progression of Barrett's esophagus in a cohort of U.S. veterans. Gastrointest Endosc 2022:S0016-5107(22)00002-5. [PMID: 34998796 DOI: 10.1016/j.gie.2021.12.034] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Sawas T, Zamani SA, Killcoyne S, Dullea A, Wang KK, Iyer PG, Fitzgerald RC, Katzka DA. Limitations of Heartburn and Other Societies' Criteria in Barrett's Screening for Detecting De Novo Esophageal Adenocarcinoma. Clin Gastroenterol Hepatol 2021:S1542-3565(21)01152-6. [PMID: 34757196 DOI: 10.1016/j.cgh.2021.10.039] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Desai M, Hamade N, Sharma P. Screening for Barrett's esophagus: challenges in identifying the population at risk. Gastrointest Endosc 2021;93:420-1. [PMID: 33478664 DOI: 10.1016/j.gie.2020.11.002] [Reference Citation Analysis]
7 Dumoulin FL, Hildenbrand R, Oyama T, Steinbrück I. Current Trends in Endoscopic Diagnosis and Treatment of Early Esophageal Cancer. Cancers (Basel) 2021;13:752. [PMID: 33670208 DOI: 10.3390/cancers13040752] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]